Molecular & Cellular Proteomics
ResearchThe Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease*Presynaptic Impairment in Alzheimer Disease
Graphical Abstract
Highlights
- •
Laser microdissection of highly vulnerable hippocampal region.
- •
Proteomic analysis of postmortem human brain tissue of AD and control cases.
- •
Decreased levels of presynaptic proteins, but not postsynaptic proteins, in AD.
- •
Immunohistochemistry verifies decreased levels of selected presynaptic proteins.
Cited by (0)
Author contributions: H.H., G.M., and S.M.N. performed research; H.H., G.M., C.E., L.M.O., L.O.T., and S.F. analyzed data; H.H., G.M., and S.F. wrote the paper; S.L.C. and A.-C.G. contributed new reagents/analytic tools; N.B., L.M.O., and S.F. designed research; B.W. and A.-C.G. input on the design and writing of the manuscript; N.B. input on writing of the manuscript; G.B. helped with interpretation of the results; L.M.O. and L.O.T. contributed to the writing of the manuscript.
- *
This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 676144 (Synaptic Dysfunction in Alzheimer Disease, SyDAD). The project was also supported by grants from Stiftelsen för gamla tjänarinnor, O.E. och Edla Johanssons Vetenskapliga Stiftelse, Demensfonden, Gun och Bertil Stohnes stiftelse, Margaretha af Ugglas Stiftelse, and Alzheimerfonden. The authors declare that they have no conflicts of interest with the contents of this article.
This article contains supplemental material.